Literature DB >> 27612080

Serial casting for elbow flexion contractures in neonatal brachial plexus palsy.

B J Duijnisveld1, D Steenbeek2, R G H H Nelissen1.   

Abstract

PURPOSE: The objective of this study was to evaluate the effectiveness of serial casting of elbow flexion contractures in neonatal brachial plexus palsy.
METHODS: A prospective consecutive cohort study was performed with a median follow-up of 5 years. Forty-one patients with elbow flexion contractures ≥ 30° were treated with serial casting until the contracture was ≤ 10°, for a maximum of 8 weeks. Range of motion, number of recurrences and patient satisfaction were recorded and analyzed using Wilcoxon signed-rank and Cox regression tests.
RESULTS: Passive extension increased from a median of -40° (IQR -50 to -30) to -15° (IQR -10 to -20, p < 0.001). Twenty patients showed 37 recurrences. The baseline severity of passive elbow extension had a hazard ratio of 0.93 (95% CI 0.89 to 0.96, p < 0.001) for first recurrence. Median patient satisfaction was moderate. Four patients showed loss of flexion mobility and in two patients serial casting had to be prematurely replaced by night splinting due to complaints.
CONCLUSION: Serial casting improved elbow flexion contractures, although recurrences were frequent. The severity of elbow flexion contracture is a predictor of recurrence. We recommend more research on muscle degeneration and determinants involved in elbow flexion contractures to improve treatment strategies and prevent side-effects.

Entities:  

Keywords:  Muscles; brachial plexus; contracture; elbow; serial casting

Mesh:

Year:  2016        PMID: 27612080     DOI: 10.3233/PRM-160381

Source DB:  PubMed          Journal:  J Pediatr Rehabil Med        ISSN: 1874-5393


  1 in total

1.  Corrective Procedure for Flexion Contracture of the Elbow in Neonatal Palsy Sequelae: Long-term Follow-up.

Authors:  Filippo Maria Sénès; Anna Maria Nucci; Annalisa Valore; Nunzio Catena
Journal:  Indian J Orthop       Date:  2021-03-10       Impact factor: 1.251

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.